13
Nov 2025
Despite advances in cancer care, treatment strategies for ampullary adenocarcinoma (AAC) remain uncertain. Its anatomic location and biological diversity lead to variable clinical behavior and outcomes.
13
Nov 2025
Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with a five-year survival rate near 50%.
13
Nov 2025
The current kidney transplant waitlisting criterion is based on a single measurement of kidney function (estimated glomerular filtration rate [eGFR] ≤20 ml/min/1.73m2) and does not consider an individual's risk of progressing to kidney failure.
13
Nov 2025
Wealth alone doesn't make a nation healthy, according to new collaborative research from the University of Surrey and its international partners which ranks 38 OECD (Organisation for Economic Co-operation and Development) countries on their progress toward global health goals.
13
Nov 2025
NYU Langone hospitals continue to receive elite distinctions in patient safety and quality, joining just 1 percent of hospitals nationwide to receive 11 consecutive "A" grades from The Leapfrog Group, a national nonprofit watchdog organization focused on healthcare safety and quality.
13
Nov 2025
As wearable health monitoring advances, the demand for flexible pressure sensors that combine high sensitivity, full-range linearity, and medical-grade accuracy continues to grow.
13
Nov 2025
Prof. Takashi Hiiragi (Hubrecht Institute), Dr. Robert Prevedel (European Molecular Biology Laboratory), and Dr. Lukas Krainer (Prospective Instruments) have launched an interdisciplinary collaboration to develop a novel intravital microscopy platform for studying mammalian embryo implantation.
13
Nov 2025
Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced today a partnership to expand access to cutting-edge 3D protein interactomics capabilities to researchers and clinicians in the United States. Carolina Molecular will be the first certified U.S. service provider for Pixelgen.
13
Nov 2025
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve chronic disease outcomes for at-risk patients, today announced a collaboration with a leading global pharmaceutical company recognized for its expertise in precision medicine and biomarker-guided drug development.
13
Nov 2025
Celleo Biotech is using the PIPETBOY GENIUS serological pipet controller from INTEGRA Biosciences to streamline the development and manufacturing of novel cell and gene therapies.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
